scorecardresearch
Monday, November 4, 2024
TopicOxford vaccine

Topic: Oxford vaccine

Oxford trial ‘lousy’, we’ll be ready with 70 cr Covaxin doses this year, says Bharat Biotech

Bharat Biotech MD Dr Krishna Ella says they gave ‘excellent safety data tested on around 25,000 participants’ & their efficacy data will be available by February-March.

Oxford vaccine to cost Rs 219-292 to govt, double for private buyers, says Adar Poonawalla

The Serum Institute of India CEO said Covishield will be sold to the govt and Global Alliance for Vaccines and Immunization countries first and on the private market later.

UK set to give first Oxford Covid vaccine shots as cases surge

Britain is recording more than 50,000 new cases daily, with the new strain that’s estimated to be as much as 70% more transmissible fueling the pandemic’s resurgence.

UK approves AstraZeneca-Oxford Covid vaccine for emergency use

The vaccine will be prioritised for the country’s most vulnerable groups. It’s the second Covid vaccine to be cleared for emergency use in the UK after Pfizer and BioNTech.

Oxford-AstraZeneca vaccine has 70% efficacy against Covid, interim results in Lancet reveal

The findings, published The Lancet, are the first full peer-reviewed efficacy results to be published for a Covid-19 vaccine.

Approval, pricing, distribution — 5 questions India faces before rolling out Covid vaccine

3 firms have applied for emergency use approval, but no clarity yet on if people will get to choose a vaccine, or what the state’s role in procurement will be.

UK asks regulator to approve Oxford-AstraZeneca vaccine for temporary supply

If authorised, the UK will be one of the first countries in the world to receive the vaccine. AstraZeneca expects to have up to 4 million doses ready by the end of 2020.

AstraZeneca plans another Covid vaccine trial to clear uncertainty and confusion

Questions are mounting over AstraZeneca vaccine after it said a lower dosage level that appeared more effective resulted from a manufacturing discrepancy.

India’s vaccine delivery roadmap and Allahabad HC’s history of ‘landmark’ verdicts

The best cartoons of the day, chosen by the editors at ThePrint.

AstraZeneca Covid vaccine’s 90% efficacy came in younger trial group

The vaccine was 90% effective when a half-dose was given before a full-dose booster. However, that regime was administered to participants in a group whose age was capped at 55.

On Camera

Trudeau is nursing snakes in his own backyard. Misguided Sikhs in Canada are losing the plot

By turning a blind eye to the snakes in his own backyard, Trudeau is setting the stage for a disaster of epic proportions for his country, his people, and the world at large.

Watch CutTheClutter: Flattening INR-USD rate, and debate on pros and cons of a ‘strong’ rupee

In Episode 1544 of CutTheClutter, Editor-in-Chief Shekhar Gupta looks at some top economists pointing to the pitfalls of ‘currency nationalism’ with data from 1991 to 2004.

India carries out 1st patrol in Depsang since disengagement with China, to take things ‘slow’

While there are patrolling points (PP) 10, 11, 12, 12A and 13 in the Depsang Plains, the patrol in the region Monday was carried out to only one point as decided by India and China.

Xi wanted to teach India about imbalance of power. We should take a budgetary lesson from it

While we talk much about our military, we don’t put our national wallet where our mouth is. Nobody is saying we should double our defence spending, but current declining trend must be reversed.